Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
- 1 June 1999
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 353 (9170), 2093-2099
- https://doi.org/10.1016/s0140-6736(98)08468-2
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Pseudo‐Cushing's Syndrome in Human Immunodeficiency Virus– Infected PatientsClinical Infectious Diseases, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Triglyceride Concentration and Ischemic Heart DiseaseCirculation, 1998
- Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial InfarctionCirculation, 1997
- Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular studyAtherosclerosis, 1996
- Combined Effects of HDL Cholesterol, Triglyceride, and Total Cholesterol Concentrations on 18-Year Risk of Atherosclerotic DiseaseCirculation, 1995
- Diabetes mellitus following treatment of AIDS with didanosineAIDS, 1995
- Validation of body composition by dual energy X‐ray absorptiometry (DEXA)Clinical Physiology and Functional Imaging, 1991
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985
- CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall StudyThe Lancet, 1980